0001585608-20-000007.txt : 20200917 0001585608-20-000007.hdr.sgml : 20200917 20200917130620 ACCESSION NUMBER: 0001585608-20-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200917 DATE AS OF CHANGE: 20200917 EFFECTIVENESS DATE: 20200917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375780 FILM NUMBER: 201180675 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 D 1 primary_doc.xml X0708 D LIVE 0001585608 Jaguar Health, Inc. 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 415-371-8300 DELAWARE Jaguar Animal Health, Inc. Corporation true Lisa Conte 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 Executive Officer Director Promoter Carol Lizak 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA CALIFORNIA 94105 Executive Officer Steven King 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA CALIFORNIA 94105 Executive Officer Jonathan Wolin 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 Executive Officer James Bochnowski 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 Director John Micek, III 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 Director Greg J. Divis 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 Director Jonathan B. Siegel 201 Mission Street, Suite 2375 SAN FRANCISCO CA CALIFORNIA 94105 Director Pharmaceuticals Decline to Disclose 06b false 2020-09-01 false true true Common Stock. false 0 1087500 1087500 0 false 1 0 0 0 false Jaguar Health, Inc. /s/ Lisa Conte Lisa Conte Chief Executive Officer 2020-09-15